Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00166257
Status:
UNKNOWN
Last Update Posted:
2009-05-27
First Post:
2005-09-09
Brief Title:
PC-Trial Patent Foramen Ovale and Cryptogenic Embolism
Sponsor:
Foundation for Cardiovascular Research Zurich
Organization:
Foundation for Cardiovascular Research Zurich
Study Overview
Official Title:
Randomized Clinical Trial Comparing the Efficacy of Percutaneous Closure of Patent Foramen Ovale PFO With Medical Treatment in Patients With Cryptogenic Embolism
Status:
UNKNOWN
Status Verified Date:
2009-05
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare two treatments strategies to prevent further attacks in patients who have suffered an stroke or occlusion of a major artery with no obvious reason other than a persistent small opening between the upper heart chambers
Detailed Description:
In patients who have suffered a stroke or occlusion of a large artery in another body part of unknown origin a possible cause is a small opening between the upper heart chambers patent foramen ovale it is called After birth this opening closes in 75 of the population while it persists in 25 of people It may allow a small blood clot to pass from the veins of the legs through the heart into the brain or other parts of the body In order to reduce the risk for a further attack we have today more therapeutic options to choose from but it is unclear which strategy have the best outcome This study is created to compare the effect of two treatment strategies
1 Medical treatment The purpose of medical treatment is to dilute the blood to a degree that no thrombus formation occurs Since the opening in the heart persists treatment is usually recommended lifelong And patients treated with coumadin must undergo regular blood tests to ensure an adequate effect of the drug
2 Catheter closure of patent foramen ovale An alternative method developed to close the small opening in the heart utilizes catheters which are introduced in a blood vessel in the groin and from there advanced to the heart An umbrella device is then delivered through the catheter positioned within the small defect and released The umbrella is overgrown with own tissue within weeks to months and closes the small defect for ever
1 Medical treatment The purpose of medical treatment is to dilute the blood to a degree that no thrombus formation occurs Since the opening in the heart persists treatment is usually recommended lifelong And patients treated with coumadin must undergo regular blood tests to ensure an adequate effect of the drug
2 Catheter closure of patent foramen ovale An alternative method developed to close the small opening in the heart utilizes catheters which are introduced in a blood vessel in the groin and from there advanced to the heart An umbrella device is then delivered through the catheter positioned within the small defect and released The umbrella is overgrown with own tissue within weeks to months and closes the small defect for ever
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None